Shuttle Pharmaceuticals Inc.

SHPH | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.81

+$0.34 (+9.80%)

Sep 22, 2026, 2:46 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+9.80%

(1D)

Rating

Updated: Aug 15, 2026

16.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $2.23M

1D Range

3.40 3.95

52W Range

2.58 55.90

Valuation (TTM)

PE -0.57

PB 0.61

EV/EBITDA -0.11

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target N/A

Cash Flow

FCF Yield -461.6%

SBC Adj. FCF Yield -482.8%

SBC Impact -4.6%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -100.1% | -77.6%

FCF 3Y | 5Y -24.7% | -40.2%

Returns

ROA -91.6%

ROE -408.3%

ROIC -312.0%

Financial Health

Net Cash

$1.01M

Current Ratio 0.30

Interest Coverage -157.45

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platfo...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 2

IPO Date Aug 30, 2022

Website www.shuttlepharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.